Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR117887 + Metformin in Type 2 Diabetes
NCT01984489Phase 2Completed
- Sponsor
- Hengrui
- Start
- Jun 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of besigliptin in type 2 diabetes mellitus (T2DM), sponsored by Hengrui. Started Jun 2012; status: completed.
02
Drugs
besigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01984489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01984489.